Aprameya Enginee

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0LQG01010
  • NSEID: APRAMEYA
  • BSEID:
INR
331.00
12.45 (3.91%)
BSENSE

Dec 05

BSE+NSE Vol: 14500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

14.5 k (2.11%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.77%

Held by 0 DIIs

Promoter

73.53%

How has been the historical performance of the Aprameya Enginee?

07-Jun-2025

Aprameya Enginee's financial performance declined from March 2023 to March 2024, with net sales dropping from Rs 78.12 crore to Rs 65.16 crore and profit after tax decreasing from Rs 5.37 crore to Rs 3.46 crore, despite an increase in total assets. The company faced challenges in revenue generation and profitability, reflected in negative cash flow from operating activities.

Answer:<BR>The historical performance of Aprameya Enginee shows a decline in key financial metrics from March 2023 to March 2024.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2024, Aprameya Enginee reported net sales of Rs 65.16 crore, down from Rs 78.12 crore in the previous year. Total operating income mirrored this decline, remaining at Rs 65.16 crore. The company's total expenditure decreased to Rs 58.80 crore from Rs 68.67 crore, leading to an operating profit (PBDIT) of Rs 6.82 crore, down from Rs 9.66 crore. Profit before tax also fell to Rs 4.60 crore from Rs 7.48 crore, resulting in a profit after tax of Rs 3.46 crore compared to Rs 5.37 crore in the prior year. The earnings per share decreased from Rs 3.84 to Rs 2.47, reflecting a decline in profitability. On the balance sheet, total assets increased to Rs 75.23 crore from Rs 61.73 crore, driven by a rise in current assets, particularly sundry debtors, which grew to Rs 58.06 crore from Rs 41.80 crore. Total liabilities also rose to Rs 75.23 crore, up from Rs 61.73 crore, with total debt increasing significantly to Rs 42.05 crore from Rs 28.74 crore. Cash flow from operating activities remained negative at Rs -9.00 crore, though cash flow from financing activities improved to Rs 11.00 crore from Rs 13.00 crore. Overall, the financial performance indicates challenges in revenue generation and profitability despite growth in total assets.

Read More

When is the next results date for Aprameya Enginee?

06-Jun-2025

No Upcoming Board Meetings

Has Aprameya Enginee declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Aprameya Enginee?

16-Jul-2025

Peers of Aprameya Enginee include Shalby, GPT Healthcare, Chandan Healthca, Unihealth Hosp, Nephro Care, KHFM Hospitality, Abate As Indust, Asarfi Hospital, and KMC Speciality. In terms of management risk, growth, and capital structure, GPT Healthcare and Chandan Healthca stand out positively, while Aprameya Enginee shows good management risk but below average capital structure.

Peers: The peers of Aprameya Enginee are Shalby, GPT Healthcare, Chandan Healthca, Unihealth Hosp, Nephro Care, KHFM Hospitality, Abate As Indust, Asarfi Hospital, and KMC Speciality.<BR><BR>Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Chandan Healthca, while Good management risk is found at Aprameya Enginee, Unihealth Hosp, Nephro Care, and Asarfi Hospital. Average management risk is present at Shalby and KHFM Hospitality, and the rest have either does not qualify or below average ratings. In terms of Growth, Excellent growth is noted at Chandan Healthca and Nephro Care, while Aprameya Enginee and Unihealth Hosp show Good growth, and the rest have either below average or do not qualify. For Capital Structure, Excellent capital structure is seen at GPT Healthcare and KMC Speciality, Good at Shalby, Chandan Healthca, and Asarfi Hospital, while Below Average is noted at Aprameya Enginee and Unihealth Hosp, and the rest have either does not qualify or below average ratings.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Unihealth Hosp at 35.24%, while Nephro Care has the lowest at -46.62%. Aprameya Enginee's 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Nephro Care, KHFM Hospitality, and Chandan Healthca.

Read More

What does Aprameya Enginee do?

17-Jul-2025

Aprameya Engineering Ltd is a micro-cap company in the hospital industry, incorporated as a Private Limited Company in December 2021. It currently has no reported sales or profits, with a market cap of INR 299 Cr and a P/E ratio of 19.00.

Overview: <BR>Aprameya Engineering Ltd operates in the hospital industry and is classified as a micro-cap company.<BR><BR>History: <BR>The company was originally formed as a Partnership Firm on September 05, 2003, and was registered on August 13, 2004, in Ahmedabad. It was subsequently incorporated as a Private Limited Company on December 28, 2021, following the conversion of the partnership firm. There is no sales or profit data reported for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 299 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 19.00 <BR>Industry P/E: 59 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.45 <BR>Return on Equity: 25.09% <BR>Price-to-Book: 4.65 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Read More

Who are the top shareholders of the Aprameya Enginee?

17-Jul-2025

The top shareholders of Aprameya Enginee include Saurabh Kishorbhai Bhatt with 36.24%, Hem Finlease Private Limited at 2.7%, and individual investors holding 20.81%. There are no pledged promoter holdings or mutual funds involved.

The top shareholders of Aprameya Enginee include the promoters, with Saurabh Kishorbhai Bhatt holding the highest stake at 36.24%. Additionally, Hem Finlease Private Limited is the largest public shareholder, owning 2.7%. The company also has some foreign institutional investors (FIIs) holding a combined 0.41%. Individual investors collectively own 20.81% of the shares. There are no pledged promoter holdings, and no mutual funds are currently involved.

Read More

How big is Aprameya Enginee?

24-Jul-2025

As of 23rd July, Aprameya Engineering Ltd has a market capitalization of 314.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

As of 23rd July, <BR><BR>Market Cap: Aprameya Engineering Ltd has a market capitalization of 314.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 64.26 Cr and Total Assets totaling 143.44 Cr.

Read More

Is Aprameya Enginee overvalued or undervalued?

29-Aug-2025

As of August 28, 2025, Aprameya Enginee is considered very expensive and overvalued with a PE ratio of 21.89, despite strong stock performance and a year-to-date return of 75.85%, especially when compared to its peers like Max Healthcare and Apollo Hospitals.

As of 28 August 2025, the valuation grade for Aprameya Enginee has moved from fair to very expensive. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 21.89, an EV to EBITDA ratio of 15.64, and a ROE of 25.09%. <BR><BR>In comparison to its peers, Aprameya Enginee's PE ratio is significantly lower than that of Max Healthcare at 93.61 and Apollo Hospitals at 70.56, both of which are also categorized as very expensive. The company's stock has shown strong performance, with a year-to-date return of 75.85%, contrasting sharply with the Sensex's return of only 3.62% during the same period. This suggests that while the stock has performed well, its current valuation does not justify the high price relative to its earnings potential.

Read More

Is Aprameya Enginee technically bullish or bearish?

02-Dec-2025

As of December 1, 2025, the trend is mildly bullish with supportive indicators like a bullish MACD and daily moving averages, but mixed signals from the monthly RSI and Dow Theory suggest caution.

As of 1 December 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a bullish MACD on the weekly chart and bullish signals from the Bollinger Bands and daily moving averages. However, the monthly RSI indicates a bearish signal, which tempers the overall bullish outlook. The lack of clear trends in Dow Theory and OBV on both weekly and monthly time frames suggests caution. Overall, while there are bullish indicators, the mixed signals indicate a moderate strength in the bullish stance.

Read More

Why is Aprameya Enginee falling/rising?

05-Dec-2025

As of 04-Dec, Aprameya Engineering Ltd's stock price is currently at 318.55, reflecting a decline of 3.44% and underperforming its sector. Despite strong long-term gains, recent short-term performance is negative, with a significant drop in investor participation and a downward trend indicated by moving averages.

As of 04-Dec, Aprameya Engineering Ltd's stock price is falling, currently at 318.55, which reflects a decrease of 11.35 or 3.44%. This decline is evident as the stock has underperformed its sector by 3.31% today. Additionally, the stock has experienced a significant drop in investor participation, with a delivery volume of 3,000 shares on December 3, which is a decrease of 75.61% compared to the 5-day average delivery volume. <BR><BR>While the stock has shown strong performance over longer periods, such as a year-to-date increase of 204.11% and a one-year increase of 281.27%, the current short-term performance is negative, with a 1-week decline of 2.58%. Furthermore, although the stock is trading higher than its 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than its 5-day moving average, indicating a recent downward trend. These factors collectively contribute to the stock's current falling price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 598 Cr (Micro Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

22.70%

stock-summary
Price to Book

8.54

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
43.23%
0%
43.23%
6 Months
83.48%
0%
83.48%
1 Year
278.94%
0%
278.94%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Aprameya Enginee for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Is Aprameya Enginee technically bullish or bearish?

Technical Trend Overview

As of 01 Dec 2025, Aprameya Enginee's technical trend has moderated from a bullish to a mildly bullish classification. This subtle change indicates that while the stock retains upward momentum, the intensity of the bullishness has softened. Such a transition often signals a period of consolidation or a potential pause before the next directional move.

Key Technical Indicators: Weekly vs Monthly Perspectives

Examining the weekly technical indicators reveals a predominantly positive sentiment. The Moving Average Convergence Divergence (MACD) on the weekly chart remains bullish, suggesting that momentum is still favouring upward price movement. Similarly, the Bollinger Bands on the weekly timeframe indicate bullishness, imp...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
31.80%
EBIT Growth (5y)
61.25%
EBIT to Interest (avg)
5.04
Debt to EBITDA (avg)
1.39
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
1.34
Tax Ratio
25.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.77%
ROCE (avg)
24.57%
ROE (avg)
22.32%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
0
Price to Book Value
8.54
EV to EBIT
26.37
EV to EBITDA
26.27
EV to Capital Employed
6.08
EV to Sales
4.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.05%
ROE (Latest)
22.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Saurabh Kishorbhai Bhatt (36.24%)

Highest Public shareholder

Hem Finlease Private Limited (1.47%)

Individual Investors Holdings

21.73%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aprameya Enginee"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -66.67% vs 1,263.86% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -62.11% vs 1,131.21% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42.14",
          "val2": "126.43",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.02",
          "val2": "25.77",
          "chgp": "-57.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.03",
          "val2": "2.03",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.76",
          "val2": "17.84",
          "chgp": "-62.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.15%",
          "val2": "20.38%",
          "chgp": "5.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aprameya Enginee"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 108.27% vs -16.59% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 361.89% vs -35.01% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "135.71",
          "val2": "65.16",
          "chgp": "108.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.40",
          "val2": "6.35",
          "chgp": "284.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.18",
          "val2": "2.11",
          "chgp": "50.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.12",
          "val2": "3.49",
          "chgp": "361.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.98%",
          "val2": "9.75%",
          "chgp": "8.23%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Mar'25
Change(%)
Net Sales
42.14
126.43
-66.67%
Operating Profit (PBDIT) excl Other Income
11.02
25.77
-57.24%
Interest
2.03
2.03
Exceptional Items
0.00
0.00
Standalone Net Profit
6.76
17.84
-62.11%
Operating Profit Margin (Excl OI)
26.15%
20.38%
5.77%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -66.67% vs 1,263.86% in Mar 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -62.11% vs 1,131.21% in Mar 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
135.71
65.16
108.27%
Operating Profit (PBDIT) excl Other Income
24.40
6.35
284.25%
Interest
3.18
2.11
50.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
16.12
3.49
361.89%
Operating Profit Margin (Excl OI)
17.98%
9.75%
8.23%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 108.27% vs -16.59% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 361.89% vs -35.01% in Mar 2024

stock-summaryCompany CV
About Aprameya Engineering Ltd stock-summary
stock-summary
Aprameya Engineering Ltd
Micro Cap
Hospital
Aprameya Engineering Limited was originally formed as a Partnership Firm in the name and style of "M/s. Aprameya Engineering" pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad. Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm "M/s. Aprameya Engineering" to a Private Limited Company.
Company Coordinates stock-summary
Icon
No Company Details Available